About Alida Biosciences
Alida Biosciences is a Healthcare company based in San Diego (United States) founded in 2020 by Byron Purse. Technology for RNA analysis is provided to advance human health. Alida Biosciences has raised $11.52 million across 6 funding rounds from investors including HHS, Genoa Ventures and FusionX Ventures. The company has 17 employees. Alida Biosciences offers products and services including EpiPlex Platform and EpiScout Software. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is Alida Biosciences Inc. Its competitors include Veracyte, Cajal Neuroscience and Cofactor Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Alida Biosciences was founded in 2020 in San Diego, United States, within the biotechnology sector focused on RNA biology. Technologies for RNA analysis are developed and offered to support the creation of medical treatments and diagnostic assays. Operations center on advancing RNA-based solutions to address health challenges, with a presence in the U.S. research ecosystem.
- Headquarters San Diego, United States
- Employees 17
- Founders Byron Purse
- SectorsHealthcare
- Email••••••••
- Website alidabio.com
- Social LinkedIn
- Legal Name Alida Biosciences Inc.
- Total Equity Funding$11.52M (USD)
in 6 rounds
- Latest Funding Round$7.52M (USD), Series A
Jun 2024
- InvestorsHHS
& 3 more
- Employee Count17
Products & Services of Alida Biosciences
Alida Biosciences offers a comprehensive portfolio of products and services, including EpiPlex Platform and EpiScout Software.
Enables mapping and quantifying RNA modifications in sequencing workflows.
Uses machine learning to transform sequencing data into biological insights.
Funding Insights of Alida Biosciences
Alida Biosciences has successfully raised a total of $11.52M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $7.52 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.52M
- Total Rounds 6
- Last Round Series A — $7.52M
- First Round $1.99M
(Aug 2021)
- Investors Count 4
All 6 funding rounds of Alida Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $7.52M | Series A | – | Genoa Ventures | |
| May 2023 | $1.43M | Grant | – | – | |
| Jul 2022 | $259,554 | Grant | – | – | |
| Jun 2022 | $2.47M | Grant | – | – | |
| May 2022 | $4M | Series A | – | – | – |
| Aug 2021 | $1.99M | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Alida Biosciences
Alida Biosciences has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Genoa Ventures and FusionX Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage VC firm focused on life science startups | genoavc.com | San Francisco, United States | ||
FusionX Ventures is engaged in early-stage startup investments. | fusionxventures.com | San Diego, USA | ||
Early-stage venture capital investments are made in specific industry verticals. | vvp.vc | Palo Alto, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Alida Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alida Biosciences
9 people are tracked at Alida Biosciences (4 in leadership, 5 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Byron Purse | Co-Founder | Leadership |
Zachary Miles | Senior Director, Protein Engineering | Leadership |
Gudrun Stengel | CEO & co-Founder | Leadership |
Eric Davis | Head Of Software And Bioinformatics | Leadership |
Quan Lam | Protein Engineering Scientist II | Team |
Vito Adrian Cantu | Senior Bioinformatics Scientist | Team |
Jerome Santos | Product Manager | Team |
Justin Kirstein | Associate Scientist 2 | Team |
Jiani Niu | Scientist | Team |
Complete people profiles for Alida Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Alida Biosciences
3 dated milestones of Alida Biosciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Alida Biosciences is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series A, of $7.5M.
Competitors of Alida Biosciences
Alida Biosciences has 3 listed competitors in our database, 3 of them funded. They include Veracyte, Cajal Neuroscience and Cofactor Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veracyte.com | 2008 | San Francisco, United States | $67.9M | 815 | Genomics-based diagnostic tests for cancer are developed. | |
| cajalneuro.com | 2020 | Seattle, United States | $96M | Neurodegenerative disease drugs are developed through genetic screening and multi-omics. | ||
| cofactorgenomics.com | 2009 | San Francisco, United States | $26.2M | 9 | Diagnostic assays are developed using RNA sequencing technology. |
Detailed competitors of Alida Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Alida Biosciences
The website of Alida Biosciences (alidabio.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 63.4% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Alida Biosciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alida Biosciences
Complete news archive for Alida Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alida Biosciences
Alida Biosciences was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Alida Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Alida Biosciences is a funded company, having raised a total of $11.52M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.99M, raised on Aug 2021.
Alida Biosciences has 17 employees.
Alida Biosciences was founded in 2020 in San Diego, United States, within the biotechnology sector focused on RNA biology. Technologies for RNA analysis are developed and offered to support the creation of medical treatments and diagnostic assays. Operations center on advancing RNA-based solutions to address health challenges, with a presence in the U.S. research ecosystem.
Alida Biosciences's top competitors include Veracyte, Cofactor Genomics and Cajal Neuroscience.
Alida Biosciences offers EpiPlex Platform and EpiScout Software.
Alida Biosciences has 4 investors. Key investors include HHS, Genoa Ventures, FusionX Ventures, and Vertical Venture Partners.
Alida Biosciences operates through Alida Biosciences Inc..